The Latest Breaking News from CVS

Walgreens reaches $683m settlement with Florida over role in opioid crisis

The company settled over claims that it exacerbated the opioid crisis in the Sunshine State.

The Independent UK · May 5, 2022

Where CVS Health Stands With Analysts

CVS Health (NYSE:CVS) has observed the following analyst ratings within the last quarter:

Benzinga · May 5, 2022

CVS Health's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, CVS Health (NYSE:CVS) earned $2.31 billion, a 78.47% increase from the preceding quarter. CVS Health also posted a total of $76.83 billion in sales, a 0.29% increase since Q4.

Benzinga · May 5, 2022

Commentary: How can bricks-and-mortar stores beat online sellers? Allow dogs

When I learned that our corner CVS and Ace Hardware didn’t prohibit customers from bringing their dogs along while shopping, I switched to these stores.

Chicago Tribune · May 4, 2022

How Markets Are Playing CVS Health, T-Mobile US

On CNBC's "Options Action," Carter Worth said CVS Health Corp (NYSE: CVS) “acts poorly going into earnings.” He added, “If you’re long, we’ll take measures.

Benzinga · May 2, 2022

$100 Invested In CVS Health 20 Years Ago Would Be Worth This Much

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.04% on an annualized basis producing an average annual return of 9.11%. Currently, CVS Health has a market capitalization of $126.21 billion.

Benzinga · Apr 29, 2022

Editorial: Feds need to ramp up COVID treatment

The nation’s response to the pandemic has taken on a new phase, as mask mandates and social distancing give way to home-based testing and outpatient treatments. That’s why it’s essential the Biden administration get its new “test-to-treat” program up to speed. With new infections rising in Florida and nationally, the…

Tribune News Service · Apr 27, 2022

5 Stocks to Buy Now if You Think We're Headed for a Bear Market

High inflation, intensifying supply chain disruptions, and rising energy prices are leading to a market downturn. Therefore, it could be wise to bet on non-cyclical stocks Diageo (DEO), PepsiCo (PEP), Unilever (UL), CVS Health (CVS), and Altria Group (MO), which are expected to survive a bear market because of the…

StockNews.com · Apr 20, 2022

Here's How Much $1000 Invested In CVS Health 20 Years Ago Would Be Worth Today

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.37% on an annualized basis producing an average annual return of 9.55%. Currently, CVS Health has a market capitalization of $135.84 billion.

Benzinga · Apr 18, 2022

How the test-to-treat pillar of the US COVID strategy is failing patients

The federal “test-to-treat” program, announced in March, is meant to reduce COVID-19 hospitalizations and deaths by quickly getting antiviral pills to people who test positive. But even as cases rise again, many Americans don’t have access to the program.

Tribune News Service · Apr 18, 2022